Parallel Screening, European Pharmaceutical Contractor

By Kwok Chow, PhD, and Anil Kane, PhD


Improving the bioavailability of poorly soluble new chemical entities is a leading challenge in drug development.

Parallel screening is a cost-effective concept for selecting a suitable drug delivery system to enhance the chance of achieving the bioavailability target in the clinic.

Download to find out more.

More About This Company